References
- Tao H, Li Z, Mei Y, Li X, Lou H, Dong L, Zhou L. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma. Int Immunopharmacol. 2020; 87:106832. doi: 10.1016/j.intimp.2020.106832
- Monteiro MS, Barros AS, Pinto J, Carvalho M, Pires-Luís AS, Henrique R, et al. Nuclear magnetic resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma. Sci Rep. 2016; 6:37275. doi: 10.1038/srep37275
- Meng H, Jiang X, Cui J, Yin G, Shi B, Liu Q, et al. Genomic analysis reveals novel specific metastatic mutations in Chinese clear cell renal cell carcinoma. Biomed Res Int. 2020; 2020:2495157. doi: 10.1155/2020/2495157
- Huang C, Li J, Zhang X, Xiong T, Ye J, Yu J, Gui Y. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma. FASEB J. 2020; 34:10623–39.
- Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015; 67:519–30.
- Chen Y, Du J, Wang Y, Shi H, Jiang Q, Wang Y, et al. MicroRNA-497-5p induces cell cycle arrest of cervical cancer cells in S phase by targeting CBX4. Onco Targets Ther. 2019; 12:10535–45.
- Mathew LK, Lee SS, Skuli N, Rao S, Keith B, Nathanson KL, et al. Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal carcinomas enhances HIF2α activity. Cancer Discov. 2014; 4:53–60.
- Tang CT, Liang Q, Yang L, Lin XL, Wu S, Chen Y, et al. RAB31 targeted by MiR-30c-2-3p regulates the GLI1 signaling pathway, affecting gastric cancer cell proliferation and apoptosis. Front Oncol. 2018; 8:554. doi: 10.3389/fonc.2018.00554
- Shukla K, Sharma AK, Ward A, Will R, Hielscher T, Balwierz A, et al. MicroRNA-30c-2-3p negatively regulates NF-kB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer. Mol Oncol. 2015; 9:1106–19.
- Dougherty AC, Hawaz MG, Hoang KG, Trac J, Keck JM, Ayes C, Deweese JE. Exploration of the role of the C-terminal domain of human DNA topoisomerase IIα in catalytic activity. ACS Omega. 2021; 6:25892–903.
- Zhang M, Liang C, Chen Q, Yan H, Xu J, Zhao H, et al. Histone H2A phosphorylation recruits topoisomerase IIa to centromeres to safeguard genomic stability. EMBO J. 2020; 39:e101863. doi: 10.15252/embj.2019101863
- Antoniou-Kourounioti M, Mimmack ML, Porter ACG, Farr CJ. The impact of the C-terminal region on the interaction of topoisomerase II alpha with mitotic chromatin. Int J Mol Sci. 2019; 20:1238. doi: 10.3390/ijms20051238
- Pei YF, Yin XM, Liu XQ. TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway. Biochim Biophys Acta Mol Basis Dis. 2018; 1864:197–207.
- Liu T, Zhang H, Yi S, Gu L, Zhou M. Mutual regulation of MDM4 and TOP2A in cancer cell proliferation. Mol Oncol. 2019; 13:1047–58.
- Wang B, Shen Y, Zou Y, Qi Z, Huang G, Xia S, et al. TOP2A promotes cell migration, invasion and epithelial–mesenchymal transition in cervical cancer via activating the PI3K/AKT signaling. Cancer Manag Res. 2020; 12:3807–14.
- Lyu WJ, Shu YJ, Liu YB, Dong P. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. Chin Med J (Engl). 2020; 133:2321–9.
- Yuan L, Zeng G, Chen L, Wang G, Wang X, Cao X, et al. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis. Int J Biol Sci. 2018; 14:266–79.
- Rezghi Barez S, Movahedian Attar A, Aghaei M. MicroRNA-30c-2-3p regulates ER stress and induces apoptosis in ovarian cancer cells underlying ER stress. EXCLI J. 2021; 20:922–34.
- Li D, Zhang Y, Li Y, Wang X, Wang F, Du J, et al. miR-149 suppresses the proliferation and metastasis of human gastric cancer cells by targeting FOXC1. Biomed Res Int. 2021; 2021:1503403. doi: 10.1155/2021/1503403
- Guidelines Working Committee of Chinese Society of Clinical Oncology. Guidelines of Chinese Society of Clinical Oncology (CSCO). Kidney Cancer. Beijing, 2015.
- Zhang C, Qu Y, Xiao H, Xiao W, Liu J, Gao Y, et al. LncRNA SNHG3 promotes clear cell renal cell carcinoma proliferation and migration by upregulating TOP2A. Exp Cell Res. 2019; 384:111595. doi: 10.1016/j.yexcr.2019.111595
- Abraham AD, Esquer H, Zhou Q, Tomlinson N, Hamill BD, Abbott JM, et al. Drug design targeting T-cell factor (TCF)-driven epithelial-mesenchymal transition as a therapeutic strategy for colorectal cancer. J Med Chem. 2019; 62:10182–203.
- Ye M, He Z, Dai W, Li Z, Chen X, Liu J. A TOP2A-derived cancer panel drives cancer progression in papillary renal cell carcinoma. Oncol Lett. 2018; 16:4169–78.
- Berglund A, Amankwah EK, Kim YC, Spiess PE, Sexton WJ, Manley B, et al. Influence of gene expression on survival of clear cell renal cell carcinoma. Cancer Med. 2020; 9:8662–75.
- Parker AS, Eckel-Passow JE, Serie D, Hilton T, Parasramka M, Joseph RW, et al. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. Eur Urol. 2014; 66:929–35.
- Chen D, Maruschke M, Hakenberg O, Zimmermann W, Stief CG, Buchner A. TOP2A, HELLS, ATAD2, and TET3 are novel prognostic markers in renal cell carcinoma. Urology. 2017; 102:265.e1–7.
- Xiong Y, Yuan L, Chen L, Zhu Y, Zhang S, Liu X, et al. Identifying a novel biomarker TOP2A of clear cell renal cell carcinoma (ccRCC) associated with smoking by co-expression network analysis. J Cancer. 2018; 9:3912–22.
- Zhang F, Wu H. MiR-599 targeting TOP2A inhibits the malignancy of bladder cancer cells. Biochem Biophys Res Commun. 2021; 570:154–61.
- Yang Z, Liu Y, Shi C, Zhang Y, Lv R, Zhang R, et al. Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways. Oncol Rep. 2017; 37:1011–9.
- de Poot SA, Lai KW, van der Wal L, Plasman K, Van Damme P, Porter AC, et al. Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis. Cell Death Differ. 2014; 21:416–26.